Instructions: Print this exam worksheet. Return to the course page using the link below. Read the course material. Enter your answers on this worksheet. Return to the course page and click the link 'Take Test.' Transfer your answers.

https://www.quantumunitsed.com/go/418

Quantum Units Education®

Adult Drug Courts and Medication-Assisted Treatment for Opioid Dependence

Disease Concept of Dependence

1. The National Association of Drug Court Professionals (NADCP) states that addiction is “in part, a neurological or neuro-chemical disorder characterized by chronic physiological changes to brain regions governing motivation, learning, attention, judgment, insight, and":

A. Impulse control

B. Affect regulation

C. Arousal

D. Concentration


MAT: An Evidence-Based Best Practice for Opioid Dependence

2. Methadone, buprenorphine, and extended-release injectable naltrexone are effective treatments for opioid use disorder and could decrease recidivism and avert drug-related crimes.

A. True

B. False


3. With recent support for MAT in the treatment of opioid dependence, there is now very high usage of MAT among drug courts to assist participants with who name illicit opioids as their primary drug of abuse.

A. True

B. False


Effective Medication Treatments for Opioid Dependence

4. Each of the following is an accurate statement about how medications for opioid dependence work EXCEPT:  

A. Methadone both reduces cravings for illicit opioids and prevents withdrawal

B. Partial agonists, such as buprenorphine, may displace or block full agonists from mu receptors and prevent the euphoric and analgesic effects of opioids

C. Methadone is an antagonist and therefore does not produce the same euphoric effects as full agonists such as heroin and morphine

D. Buprenorphine reduces cravings for and withdrawal symptoms from opioids and has limited side effects and contraindications


5. As a maintenance medication, methadone is used to stabilize and control the opioid dependence, and it is effective only for as long as the patient takes it.

A. True

B. False


Extended-Release Injectable Naltrexone

6. Which of the following accurately describes the use of extended-released injectable naltrexone to prevent relapse to opioid use?

A. Naltrexone is a relatively safe opioid antagonist that fully blocks the effects of opioids such as heroin and oxycodone

B. A person who is dependent on opioids must be withdrawn from all opioids for 7 to 10 days before receiving extended-release injectable naltrexone, or he or she will undergo withdrawal symptoms immediately

C. Extended-release naltrexone is not a controlled substance and has no abuse or diversion potential, offering an alternative to methadone or buprenorphine

D. All of the above


7. One of the greatest advantages of extended-release injectable naltrexone is that it is well tolerated by most users and can safely be used for patients with acute hepatitis.

A. True

B. False


Increasing the Use of MAT in Drug Court Programs

8. An important first step toward increasing the use of MAT in drug court programs is to:

A. Examine barriers to its use

B. Train drug court personnel on its effectiveness

C. Identify existing problems with MAT in order to educate potential users

D. Develop relationships with current MAT providers so that they may be used as a resource


Copyright © 2019 Quantum Units Education

Visit us at QuantumUnitsEd.com!